Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001209191-15-040941
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2015-05-11 12:34:33
Reporting Period:
2014-11-05
Filing Date:
2015-05-11
Accepted Time:
2015-05-11 12:34:33
Original Submission Date:
2014-11-07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1294133 Inogen Inc INGN Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1201585 B Rebecca Robertson One Sansome Street
Suite 3630
San Francisco CA 94104
No No Yes No
1279592 N Barbara Lubash One Sansome Street
Suite 3630
San Francisco CA 94104
No No Yes No
1354131 Versant Venture Capital Ii, Lp One Sansome Street
Suite 3630
San Francisco CA 94104
No No Yes No
1354132 Versant Affiliates Fund Ii-A, Lp One Sansome Street
Suite 3630
San Francisco CA 94104
No No Yes No
1354307 Versant Side Fund Ii, Lp One Sansome Street
Suite 3630
San Francisco CA 94104
No No Yes No
1354345 Phd J Bradley Bolzon One Sansome Street
Suite 3630
San Francisco CA 94104
No No Yes No
1354727 Versant Ventures Ii Llc One Sansome Street
Suite 3630
San Francisco CA 94104
No No Yes No
1354802 M Charles Warden One Sansome Street
Suite 3630
San Francisco CA 94104
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-11-05 3,476 $0.00 26,061 No 4 J Indirect See Footnote
Common Stock Disposition 2014-11-05 389,136 $0.00 2,917,544 No 4 J Indirect See Footnote
Common Stock Acquisiton 2014-11-05 42,216 $0.00 42,216 No 4 J Indirect See Footnote
Common Stock Disposition 2014-11-05 42,216 $0.00 0 No 4 J Indirect See Footnote
Common Stock Acquisiton 2014-11-05 243 $0.00 243 No 4 J Indirect By Robertson Family Trust
Common Stock Acquisiton 2014-11-05 2,798 $0.00 3,041 No 4 J Indirect By Robertson Family Trust
Common Stock Acquisiton 2014-11-05 5,596 $0.00 5,596 No 4 J Indirect By Lubash Mosses LLC and Evan Michael Moses Trust
Common Stock Acquisiton 2014-11-05 5,199 $0.00 13,640 No 4 J Indirect By Bradley Bolzon
Common Stock Acquisiton 2014-11-05 1,469 $0.00 3,782 No 4 J Indirect By Charles Warden
Common Stock Disposition 2014-11-06 4,238 $24.56 58,495 No 4 S Indirect See Footnote
Common Stock Disposition 2014-11-07 3,150 $23.95 55,345 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 J Indirect See Footnote
No 4 J Indirect See Footnote
No 4 J Indirect See Footnote
No 4 J Indirect See Footnote
No 4 J Indirect By Robertson Family Trust
No 4 J Indirect By Robertson Family Trust
No 4 J Indirect By Lubash Mosses LLC and Evan Michael Moses Trust
No 4 J Indirect By Bradley Bolzon
No 4 J Indirect By Charles Warden
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Footnotes
  1. Represents a pro-rata in-kind distribution of Common Stock of the Issuer for no consideration by Versant Side Fund II, L.P. ("VSF II") to its partners.
  2. Shares held by VSF II. Versant Ventures II, LLC ("VV II") serves as the sole general partner of VSF II. Brian G. Atwood, Samuel D. Colella, Ross A. Jaffe, William J. Link, Ph.D., Donald B. Milder, Rebecca B. Robertson, Bradley J. Bolzon, Charles M. Warden, and Barbara N. Lubash are directors and/or members of VV II and share voting and dispositive power over the shares held by VSF II, however, each disclaim beneficial ownership of these shares, except to the extent of their pecuniary interest in such shares.
  3. Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Versant Venture Capital II, L.P. ("VVC II") without consideration to its partners.
  4. Shares held by VVC II. VV II serves as the sole general partner of VVC II. Brian G. Atwood, Samuel D. Colella, Ross A. Jaffe, William J. Link, Ph.D., Donald B. Milder, Rebecca B. Robertson, Bradley J. Bolzon, Charles M. Warden, and Barbara N. Lubash are directors and/or members of VV II and share voting and dispositive power over the shares held by VVC II, however, each disclaim beneficial ownership of these shares, except to the extent of their pecuniary interest in such shares.
  5. Represents a change in the form of ownership by virtue of the receipt of shares in the pro-rata distribution of Common Stock of the Issuer by VVC II.
  6. The shares are held by VV II. Brian G. Atwood, Samuel D. Colella, Ross A. Jaffe, William J. Link, Ph.D., Donald B. Milder, Rebecca B. Robertson, Bradley J. Bolzon, Charles M. Warden and Barbara N. Lubash are directors and/or members of VV II and share voting and dispositive power over the shares held by VV II, however, each disclaim beneficial ownership of these shares except to the extent of their pecuniary interest therein.
  7. Represents a pro-rata in-kind distibution of Common Stock of the Issuer by VV II without consideration to its members.
  8. The shares are held by the Robertson Family Trust (the "Trust") for the benefit of Rebecca B. Robertson. Rebecca B. Robertson is a trustee of the Trust.
  9. The shares are held Lubash Moses LLC for the benefit of Barbara N. Lubash (the "LLC") for the benefit of Barbara N. Lubash. Barbara N. Lubash is a manager of the LLC.
  10. The shares are held by the Evan Michael Moses Trust for the benefit of Barbara N. Lubash.
  11. The shares are held by Bradley J. Bolzon.
  12. The shares are held by Charles M. Warden.
  13. Price reflected is the weighted-average sale price for shares sold. The range of the sale prices for the transaction was $24.13 and $24.87 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or security holder of the Issuer, full information regarding the number of shares sold at each sepate price.
  14. Shares held by Versant Affiliates Fund II-A, L.P. ("VAF II-A"). VV II serves as the sole general partner of VAF II-A. Brian G. Atwood, Samuel D. Colella, Ross A. Jaffe, William J. Link, Ph.D., Donald B. Milder, Rebecca B. Robertson, Bradley J. Bolzon, Charles M. Warden, and Barbara N. Lubash are directors and/or members of VV II and share voting and dispositive power over the shares held by VAF II-A, however, each disclaim beneficial ownership of these shares, except to the extent of their pecuniary interest in such shares.
  15. Price reflected is the weighted-average sale price for shares sold. The range of the sale prices for the transaction was $23.475 and $24.34 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or security holder of the Issuer, full information regarding the number of shares sold at each sepate price.